CGC

Canopy Growth Corporation (CGC) | Rumor.io

Canopy Growth

CGC

Attention (50-day avg)0.02%

Attention rank (50-day avg)#322

Bullish sentiment (50-day avg)84%

Price to earnings ratio-1.05

Market capitalization415.6M

Earnings per share-0.48

Dividend yield (TTM)—

Revenue (annual)284.6M

Net income (annual)-262.9M

Social

What share of all stock conversation is about CGC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.01	0.02% +0.01	0.02% +0	0.02% -0.02

Sep 25

Canopy Growth's reverse split vote is scheduled for October 23, as the meeting was adjourned due to lack of quorum.
The reverse split authorization has expired, and a new one may not be in place by October 23, potentially making the vote irrelevant.
The company's insider trades have been scrutinized, with one investor claiming to have sold shares after observing insider selling.

Generated by AI

Sentiment

Of the messages about CGC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	72.03% -22.58	81.42% -5.01	87.66% -1.56
Bearish	0% 0	27.97% +22.58	18.58% +5.01	12.34% +1.56

Bullish· Sep 22

Canopy Growth Corporation's (CGC) revenue increase is a positive sign for the company's future growth.
The company's expansion into the UK medical-cannabis market, particularly through its partnership with GROW Group, provides a new sales channel and access to a established European market.
With increased volume and insiders buying the stock, it appears that the bottom is in and the company is on the path to recovery, with the 50-day moving average being retested and holding.

Bearish· Jul 2

The DOJ's opposition to Schedule III is driven by financial interests, weakening their arguments.
Canopy Growth's stock may experience a significant price increase if Schedule III is rescheduled, leading to consolidation and potentially reaching double digits.
The shorts are at risk of being squeezed as the price approaches $1.06, with a high short premium on the float.

Generated by AI

Topics

Of the messages about CGC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	50%	2.44%	7.95%	8.2%
Technical Analysis	0%	32.47%	4.86%	28.67%
Macro	0%	32.47%	43.59%	34.1%
Controversies	50%	0.15%	0.03%	0.41%
Analysts	0%	32.47%	43.56%	27.94%
Earnings	0%	0%	0%	0.68%

Earnings· Nov 7

Canopy Growth Corporation ($CGC) reported Q2 earnings, beating EPS estimates by 93% and achieving a net positive balance sheet for the first time.
The company's Q2 revenue of $66.68M missed estimates, but Canada adult-use revenue grew 30% and medical revenue grew 17%, with cash and cash equivalents exceeding debt balances by $70M.
Canopy Growth's financial performance continues to improve, with adjusted EBITDA and cost management showing significant progress, and the company is on track to be profitable in the coming quarters.

Analysts· Jun 2

Canaccord Genuity upgraded Canopy Growth to "hold" from "sell" and lowered the target price to C$30 from C$32.
Multiple analysts, including CFRA, Cowen and Company, CIBC, and MKM Partners, cut their target prices for Canopy Growth, ranging from C$29 to C$45.
Canaccord Genuity analyst Matt Bottomley upgraded Canopy Growth to "hold" from "sell" and lowered the price target to C$30, while Eight Capital upgraded the company to "neutral".

Announcements· Jan 9

Canopy Growth files for 52,279,795 common share offering by selling shareholders to raise capital.
The company issued C$55M in convertible notes and 12.7M warrants as part of a debt exchange, with the convertible notes convertible into 30.1M shares.
Canopy Growth registered a resale of common shares, which were issued to selling securityholders in a private placement, including 9.5M shares, 12.7M warrants, and 30M convertible debentures.

Controversies· Nov 21

Canopy Growth Corporation ($CGC) is facing lawsuits alleging securities fraud, with multiple law firms announcing class-action lawsuits.
The company has commented on the class securities litigation, stating that it is aware of the suits and will defend itself vigorously.
Lawsuits against $CGC have been filed by several law firms, including Bragar Eagel & Squire, P.C. and The Schall Law Firm, alleging false and misleading statements by the company.

Macro· May 1

Canopy Growth Corporation's stock is expected to reach $30 today, according to a comment.
Jim Cramer identifies Canopy Growth as the best pot stock in the market, citing its potential for growth and support levels at $6.
Canopy Growth's weekly chart analysis suggests a possible support level at $6, which could be an important level to watch.

Technical Analysis· Dec 19

Canopy Growth's ($CGC) price needs to break the $192.00 resistance for meaningful upside.
The stock's breakout is dependent on closing the week above $2.00, with a pullback possible to $1.30-1.50 if it stays below $2.00.
The chart indicates a possible head and shoulder pattern, with a potential floor at $1.50 and a rejected peak at $2.38.

Generated by AI

Community

Of the messages about CGC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	24.94%	82.4%	66.27%
Newcomers	0%	75.06%	17.6%	33.73%

Regulars· Sep 25

The Canopy Growth Corporation (CGC) is expected to hold an October meeting to address business, including a potential reverse split, after adjourning its 2026 Annual General and Special Meeting due to lack of quorum.
Regulars are expressing concerns that management may prioritize a reverse split over natural stock price growth, and are advocating for the company to cut staff or sell assets to raise the stock price instead.
The company's insider trades are being closely watched, with one regular noting that they took a loss of $20 after selling shares, implying that insiders may have knowledge about the company's plans.

Newcomers· Sep 24

New users are excited about Canopy Growth Corporation's potential for growth in the cannabis industry.
Some newcomers are comparing Canopy Growth's stock price to other cannabis companies, looking for opportunities to invest.
There is interest in Canopy Growth's expansion plans, including its international partnerships and product offerings.

Generated by AI

SMITHS FALLS, Ontario, September 28, 2026--Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the appointment of Sebastian Blöte as Country Manager for Germany, effective October 1, 2026.

2d agoYahoo Finance

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts

Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +1.45% move from the prior day.

4d agoYahoo Finance

Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

Business Wire Press Release.

4d agoThe Globe and Mail

Canopy Growth adjourns shareholder meeting due to lack of quorum

4d agoInvesting.com

Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market

Canopy Growth Corporation (CGC) closed the most recent trading day at $0.94, moving 2.34% from the previous trading session.

6d agoYahoo Finance

Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?

6d agoYahoo Finance

Also Discussed

Investors talking about CGC also mention

#	Name	Attention
1	Aurora Cannabis Inc.ACB	0%-0.01
2	Cronos Group Inc.CRON	0%+0
3	Tilray Brands Inc.TLRY	0.02%0
4	Constellation Brands Inc. Class ASTZ	0%-0.01
5	AdvisorShares Pure US Cannabis ETFMSOS	0.49%-0.18
6	Village Farms International Inc.VFF	0.01%-0.01
7	HEXO - HEXO Corp.	——
8	Roundhill Cannabis ETFWEED	0%0
9	Organigram Global Inc.OGI	0%0
10	Amplify Alternative Harvest ETFMJ	0%new

Canopy Growth Corporation

Healthcare
Drug Manufacturers - Specialty & Generic

Canopy Growth Corporation is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-related products for medical and adult-use markets. Its business spans a range of product categories, including dried flower, oils, softgels, infused pre-rolls, and vaporizers, supported by brands such as Tweed, Doja, LivRelief, Ace Valley, and Deep Space. The company operates through its Cannabis and Storz & Bickel segments, serving customers in Canada and selected international markets, including Europe and Germany. Canopy Growth also maintains a presence in medical cannabis and related wellness products, with an emphasis on regulated supply chains, branded consumer offerings, and international compliance capabilities. Headquartered in Smiths Falls, Ontario, Canopy Growth plays a notable role in the global cannabis market as a diversified producer and distributor with both medical and consumer-focused product lines.

Website

Location

1 Hershey Drive

Smiths Falls, ON, K7A 0A8

Canada

Social

What share of all stock conversation is about CGC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.01	0.02% +0.01	0.02% +0	0.02% -0.02

Sep 25

Canopy Growth's reverse split vote is scheduled for October 23, as the meeting was adjourned due to lack of quorum.
The reverse split authorization has expired, and a new one may not be in place by October 23, potentially making the vote irrelevant.
The company's insider trades have been scrutinized, with one investor claiming to have sold shares after observing insider selling.

Generated by AI

Sentiment

Of the messages about CGC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	72.03% -22.58	81.42% -5.01	87.66% -1.56
Bearish	0% 0	27.97% +22.58	18.58% +5.01	12.34% +1.56

Bullish· Sep 22

Canopy Growth Corporation's (CGC) revenue increase is a positive sign for the company's future growth.
The company's expansion into the UK medical-cannabis market, particularly through its partnership with GROW Group, provides a new sales channel and access to a established European market.
With increased volume and insiders buying the stock, it appears that the bottom is in and the company is on the path to recovery, with the 50-day moving average being retested and holding.

Bearish· Jul 2

The DOJ's opposition to Schedule III is driven by financial interests, weakening their arguments.
Canopy Growth's stock may experience a significant price increase if Schedule III is rescheduled, leading to consolidation and potentially reaching double digits.
The shorts are at risk of being squeezed as the price approaches $1.06, with a high short premium on the float.

Generated by AI

Topics

Of the messages about CGC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	50%	2.44%	7.95%	8.2%
Technical Analysis	0%	32.47%	4.86%	28.67%
Macro	0%	32.47%	43.59%	34.1%
Controversies	50%	0.15%	0.03%	0.41%
Analysts	0%	32.47%	43.56%	27.94%
Earnings	0%	0%	0%	0.68%

Earnings· Nov 7

Canopy Growth Corporation ($CGC) reported Q2 earnings, beating EPS estimates by 93% and achieving a net positive balance sheet for the first time.
The company's Q2 revenue of $66.68M missed estimates, but Canada adult-use revenue grew 30% and medical revenue grew 17%, with cash and cash equivalents exceeding debt balances by $70M.
Canopy Growth's financial performance continues to improve, with adjusted EBITDA and cost management showing significant progress, and the company is on track to be profitable in the coming quarters.

Analysts· Jun 2

Canaccord Genuity upgraded Canopy Growth to "hold" from "sell" and lowered the target price to C$30 from C$32.
Multiple analysts, including CFRA, Cowen and Company, CIBC, and MKM Partners, cut their target prices for Canopy Growth, ranging from C$29 to C$45.
Canaccord Genuity analyst Matt Bottomley upgraded Canopy Growth to "hold" from "sell" and lowered the price target to C$30, while Eight Capital upgraded the company to "neutral".

Announcements· Jan 9

Canopy Growth files for 52,279,795 common share offering by selling shareholders to raise capital.
The company issued C$55M in convertible notes and 12.7M warrants as part of a debt exchange, with the convertible notes convertible into 30.1M shares.
Canopy Growth registered a resale of common shares, which were issued to selling securityholders in a private placement, including 9.5M shares, 12.7M warrants, and 30M convertible debentures.

Controversies· Nov 21

Canopy Growth Corporation ($CGC) is facing lawsuits alleging securities fraud, with multiple law firms announcing class-action lawsuits.
The company has commented on the class securities litigation, stating that it is aware of the suits and will defend itself vigorously.
Lawsuits against $CGC have been filed by several law firms, including Bragar Eagel & Squire, P.C. and The Schall Law Firm, alleging false and misleading statements by the company.

Macro· May 1

Canopy Growth Corporation's stock is expected to reach $30 today, according to a comment.
Jim Cramer identifies Canopy Growth as the best pot stock in the market, citing its potential for growth and support levels at $6.
Canopy Growth's weekly chart analysis suggests a possible support level at $6, which could be an important level to watch.

Technical Analysis· Dec 19

Canopy Growth's ($CGC) price needs to break the $192.00 resistance for meaningful upside.
The stock's breakout is dependent on closing the week above $2.00, with a pullback possible to $1.30-1.50 if it stays below $2.00.
The chart indicates a possible head and shoulder pattern, with a potential floor at $1.50 and a rejected peak at $2.38.

Generated by AI

Community

Of the messages about CGC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	24.94%	82.4%	66.27%
Newcomers	0%	75.06%	17.6%	33.73%

Regulars· Sep 25

The Canopy Growth Corporation (CGC) is expected to hold an October meeting to address business, including a potential reverse split, after adjourning its 2026 Annual General and Special Meeting due to lack of quorum.
Regulars are expressing concerns that management may prioritize a reverse split over natural stock price growth, and are advocating for the company to cut staff or sell assets to raise the stock price instead.
The company's insider trades are being closely watched, with one regular noting that they took a loss of $20 after selling shares, implying that insiders may have knowledge about the company's plans.

Newcomers· Sep 24

New users are excited about Canopy Growth Corporation's potential for growth in the cannabis industry.
Some newcomers are comparing Canopy Growth's stock price to other cannabis companies, looking for opportunities to invest.
There is interest in Canopy Growth's expansion plans, including its international partnerships and product offerings.

Generated by AI

Canopy Growth

Social

Sep 25

Bullish· Sep 22

Bearish· Jul 2

Earnings· Nov 7

Analysts· Jun 2

Announcements· Jan 9

Controversies· Nov 21

Macro· May 1

Technical Analysis· Dec 19

Regulars· Sep 25

Newcomers· Sep 24

Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts

Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

Canopy Growth adjourns shareholder meeting due to lack of quorum

Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market

Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?

Also Discussed

Canopy Growth Corporation

Company Information

Location

Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts

Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

Canopy Growth adjourns shareholder meeting due to lack of quorum

Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market

Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?

Also Discussed

Social

Sep 25

Bullish· Sep 22

Bearish· Jul 2

Earnings· Nov 7

Analysts· Jun 2

Announcements· Jan 9

Controversies· Nov 21

Macro· May 1

Technical Analysis· Dec 19

Regulars· Sep 25

Newcomers· Sep 24